Major study tests 12-Week cure for hepatitis c in cambodian youth
NCT ID NCT05992077
Summary
This study aims to test how well a 12-week combination pill (sofosbuvir/daclatasvir) works to clear the Hepatitis C virus in children and teenagers in Cambodia. It will involve up to 21,000 young people, first screening them for the virus and then treating those who are infected. The main goal is to see if the virus remains undetectable 12 weeks after finishing the treatment, while also checking the drug's safety and how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Battambang Provincial Hospital
Battambang, Cambodia
-
Jayavarman VII Hospital
Siem Reap, Cambodia
-
Kantha Bopha Hospital
Phnom Penh, Cambodia
-
National Pediatric Hospital
Phnom Penh, Cambodia
Conditions
Explore the condition pages connected to this study.